Harvard Bioscience
HBIO
HBIO
80 hedge funds and large institutions have $143M invested in Harvard Bioscience in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.89% more ownership
Funds ownership: 6.54% → 7.43% (+0.89%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
80
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.71M | |
| 2 | +$2.61M | |
| 3 | +$2.31M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.55M |
| 5 |
RA
Royce & Associates
New York
|
+$1.38M |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$847K | |
| 3 | -$812K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$552K |
| 5 |
Axa
Paris,
France
|
-$491K |